The mission of the Bronchiectasis and NTM Association is to improve the lives of people with bronchiectasis, NTM lung disease, or both conditions. We accomplish this by providing education, supporting advocacy, furthering research, and advancing high-quality, specialized care. Our organization offers a variety of programs including an online social community, a comprehensive website with robust educational materials and resources, a global disease awareness campaign, a longitudinal patient registry, and a large network of centers collaborating to improve patient care. We collaborate with a variety stakeholders, including patients, caregivers, health care providers, industry companies, and government entities, understanding the importance that each stakeholder group plays in working towards our mission. Our medical and scientific leadership includes Dr. Doreen Addrizzo-Harris, who oversees the Bronchiectasis and NTM Care Center Network, Dr. Timothy Aksamit, who oversees our educational resource development and World Bronchiectasis Day campaign, and Dr. Charles Daley, who oversees our research programs.
Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. To deliver on our mission to transform patient care and improve outcomes through personalized diagnostics, we provide advanced diagnostic tests and custom diagnostic development services. | Biodesix is a leading diagnostic solutions and services company with a focus in lung disease. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood-based Nodify Lung® Nodule Risk Assessment testing portfolio evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ portfolio supports treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting the time to treatment. For more information, www.biodesix.com.